This HTML5 document contains 133 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n10http://dx.doi.org/10.1089/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n12http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q44590524
rdf:type
wikibase:Item
schema:description
bilimsel makale vitskapeleg artikkel επιστημονικό άρθρο tieteellinen artikkeli 2009年学术文章 наукова стаття, опублікована в листопаді 2009 artikull shkencor vedecký článok 2009년 논문 სამეცნიერო სტატია artykuł naukowy artículo científico publicado en 2009 naučni članak 2009年学术文章 научна статия 2009年学术文章 научни чланак artigo científico scientific article published in November 2009 artigo científico wissenschaftlicher Artikel 2009年の論文 2009年學術文章 vitenskapelig artikkel tudományos cikk vetenskaplig artikel videnskabelig artikel scientific article published in November 2009 2009年學術文章 articol științific scienca artikolo bài báo khoa học 2009年学术文章 wetenschappelijk artikel artículu científicu vědecký článek 2009年學術文章 2009 nî lūn-bûn научни чланак 2009年学术文章 บทความทางวิทยาศาสตร์ مقالة علمية نشرت في نوفمبر 2009 article scientifique мақолаи илмӣ artikulong pang-agham научная статья scientific article published in November 2009 2009年學術文章 2009年学术文章 article scientific teaduslik artikkel artigo científico artikel ilmiah 2009年學術文章 নভেম্বর ২০০৯-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ מאמר מדעי article científic articolo scientifico
p:P577
wds:Q44590524-74E0A922-E602-4DBF-A442-BB5E59393357
wdt:P577
2009-11-01T00:00:00Z
p:P2093
wds:Q44590524-E209D38A-3A74-46BB-BCAF-6501D5BF7A7D wds:Q44590524-CC41737D-183C-428C-B8C7-29E00F1BE566 wds:Q44590524-D3CB41DA-9DCD-4A8E-A800-C3EA593440DE wds:Q44590524-C6DEC4DC-EC90-4BEF-9EDE-28A4D769195F wds:Q44590524-C8E9FD98-FDC7-480E-BDF6-D994FFD4AFA6 wds:Q44590524-BEC7D5C0-D013-4F5E-8768-107A471A1577 wds:Q44590524-F1AAC04D-66FE-4AE4-AEC6-2873D19C05F2 wds:Q44590524-E48C4D62-A404-487D-86CD-80D9191FC4DB wds:Q44590524-6EA1054A-D8D8-48D8-B7F5-6CF85350AE6E wds:Q44590524-5E5B7C0E-D4BC-4F01-8E82-5534D2C5EA9C wds:Q44590524-6269DD70-D5A7-423E-A542-99EE8E605B03 wds:Q44590524-537BE86D-04D0-42C2-98A3-97EFBEBB7480 wds:Q44590524-560B3C17-27EA-4BCD-A60A-E6A8F5440BA6 wds:Q44590524-4C5051CF-1B1B-45D9-AF50-9B01F71D68AD wds:Q44590524-A70985EF-43E4-42E7-A01D-5435075C0477 wds:Q44590524-966136C1-629B-4478-A34B-6A6CE49F199D wds:Q44590524-71362B7F-828E-46F3-9ADA-E9FF121B48DE wds:Q44590524-35548815-1880-414B-BEA7-246CC0F47433 wds:Q44590524-42C98ADD-A1C8-4321-8EB3-DF56D68C0E67 wds:Q44590524-11427E65-4272-4799-8D69-1E883C78A1B8
wdt:P2093
Gwynneth Stevens Paranji Ramaiyengar Narayanan Angela Lombardo Kelley Loughran Pattabiraman Sathyamoorthy James Ackland Jill Gilmour Peter Hayes Sekhar Chakrabarty Carl Verlinde Burc Barin Eddy Sayeed Patricia Fast Vadakkuppatu Devasenapathi Ramanathan Jayashri Mahalingam Michelle Seth Smith Dani Vooijs Makesh Kumar Tony Tarragona-Fiol Dennis Panicali
rdfs:label
A Phase 1 study to evaluate the safety and immunogenicity of a recombinant HIV type 1 subtype C-modified vaccinia Ankara virus vaccine candidate in Indian volunteers A Phase 1 study to evaluate the safety and immunogenicity of a recombinant HIV type 1 subtype C-modified vaccinia Ankara virus vaccine candidate in Indian volunteers
skos:prefLabel
A Phase 1 study to evaluate the safety and immunogenicity of a recombinant HIV type 1 subtype C-modified vaccinia Ankara virus vaccine candidate in Indian volunteers A Phase 1 study to evaluate the safety and immunogenicity of a recombinant HIV type 1 subtype C-modified vaccinia Ankara virus vaccine candidate in Indian volunteers
schema:name
A Phase 1 study to evaluate the safety and immunogenicity of a recombinant HIV type 1 subtype C-modified vaccinia Ankara virus vaccine candidate in Indian volunteers A Phase 1 study to evaluate the safety and immunogenicity of a recombinant HIV type 1 subtype C-modified vaccinia Ankara virus vaccine candidate in Indian volunteers
p:P50
wds:Q44590524-C16E0E6E-E03E-479D-AD07-0FE8D4468891 wds:Q44590524-AA9533B4-463B-48A4-8758-BFF159896AB2 wds:Q44590524-4506AA87-F8E2-40CA-B748-43809D34432A wds:Q44590524-245F67AA-1AEA-463F-B876-179CEBC10EFA
wdt:P50
wd:Q20738697 wd:Q59690019 wd:Q64869594 wd:Q55473907
p:P1476
wds:Q44590524-685041A6-CF8E-42FD-84DA-B588C0184773
wdt:P1476
A Phase 1 study to evaluate the safety and immunogenicity of a recombinant HIV type 1 subtype C-modified vaccinia Ankara virus vaccine candidate in Indian volunteers
p:P304
wds:Q44590524-96151271-F6B1-48BF-AC95-202CF96DFCE9
wdt:P304
1107-1116
p:P31
wds:Q44590524-D91027BE-69FA-426E-91D4-BE5DA790C0A8
wdt:P31
wd:Q13442814
p:P698
wds:Q44590524-E788259C-C164-4ABD-AB35-8D3378853017
wdtn:P698
n12:19943789
wdt:P698
19943789
p:P1433
wds:Q44590524-9B6839FF-B863-4AC8-B69A-EEBCA74A40F4
wdt:P1433
wd:Q4651880
p:P433
wds:Q44590524-1307232D-0B3F-4FB6-A83B-7D73106D09BC
p:P478
wds:Q44590524-1C081DA3-9BF8-469C-8294-64682B57AC56
wdt:P433
11
wdt:P478
25
p:P356
wds:Q44590524-9A18D449-C842-4E4D-BFC7-EB13C1288E0F
wdtn:P356
n10:AID.2009.0096
wdt:P356
10.1089/AID.2009.0096